Cecilia Pompili, Associate Professor and Thoracic Surgeon focusing on Patient Reported Outcomes Research at the University of Hull, shared a post on X:
“How do treatments impact quality of life in NSCLC?
Dr Giddings systematic review and meta-analysis at BTOG26 shows:
- Targeted therapies – early improvements
- Chemotherapy – temporary worsening
- Surgery – longer-term QoL challenges
Evidence like this is key for shared decision-making in lung cancer care.”
Other articles featuring Cecilia Pompili on OncoDaily.
